Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 73,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'catslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 73,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/growing-crisis-of-drug-prices-18370/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/growing-crisis-of-drug-prices-18370/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'catslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 73
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 74,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'artileslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 74,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/growing-crisis-of-drug-prices-18370/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/growing-crisis-of-drug-prices-18370/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'artileslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 74
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]
Code Context
            if (Configure::read('debug')) {

                trigger_error($message, E_USER_WARNING);

            } else {
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f3f8cc71fea-trace').style.display = (document.getElementById('cakeErr67f3f8cc71fea-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f3f8cc71fea-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f3f8cc71fea-code').style.display = (document.getElementById('cakeErr67f3f8cc71fea-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f3f8cc71fea-context').style.display = (document.getElementById('cakeErr67f3f8cc71fea-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f3f8cc71fea-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f3f8cc71fea-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 18241,
		&#039;title&#039; =&gt; &#039;Growing crisis of drug prices&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div style=&quot;text-align: justify&quot;&gt;
-The Hindu
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
India&amp;rsquo;s drug price control order, which is vital to the availability of affordable essential medicines, has been whittled down to the point of becoming insignificant. While the number of price-controlled medicines has dwindled over the past three decades, from 347 to 74, the pharmaceutical industry has been pursuing super profits. The High Level Expert Group of the Planning Commission on Universal Health Coverage noted in its report that price variation of therapeutically similar drugs based on brand could be as much as 1,000 per cent in the market; low official procurement prices for similar drugs were found to vary by a staggering 100 to 5,000 per cent in relation to market prices. Given these trends, it is unsurprising that 74 per cent of out-of-pocket spending on health by Indians is towards medicines. The distressing reality is that millions go without medications because they cannot afford them and they are not available free from government facilities. Activists have justifiably sought the intervention of the Supreme Court, and the Centre has the responsibility to act quickly. At this stage, it ill-serves the goal to merely expand the National List of Essential Medicines, without arriving at a rational price control formula. Here, the system of cost-based pricing with provision to add post-manufacturing expenses can be built upon, since ingredient and other costs are transparent under declarations made by producers for taxation purposes.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Direct control of drug prices is unavoidable in India because the option of indirect control at the time of procurement by public health agencies and insurers is not yet available, as in Europe and the U.S. Citizens in developed countries are insulated from the vagaries of market pricing: they either do not pay at the point of treatment or get a cash reimbursement. But even here, there is the Tamil Nadu model &amp;mdash; under which the pharmaceutical industry supplies quality drugs at a fraction of the market price. What this proves is that the price of a drug in the market cannot be several hundred per cent more than what is paid by official agencies. In the sample case of anti-hypertensive drug atenolol, in 2008-09 prices, a strip of tablets was procured officially by Tamil Nadu for Rs.1.20, while consumers bought it for Rs. 26.30 from the market leader. Clearly, the case for reform and cost-based pricing cannot be overstated. The Centre must also plug loopholes that help manufacturers evade price controls by producing combinations of essential and other medications. A panel of professionals to examine all medicines consumed in the country must be constituted, to prepare a more exhaustive and relevant list of essential drugs.&amp;nbsp;
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Hindu, 30 November, 2012, http://www.thehindu.com/opinion/editorial/growing-crisis-of-drug-prices/article4147475.ece&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;growing-crisis-of-drug-prices-18370&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 18370,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 18241,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Growing crisis of drug prices&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;medicines,Health,Inflation&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Hindu





India&amp;rsquo;s drug price control order, which is vital to the availability of affordable essential medicines, has been whittled down to the point of becoming insignificant. While the number of price-controlled medicines has dwindled over the past three decades, from...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div style=&quot;text-align: justify&quot;&gt;-The Hindu&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;India&amp;rsquo;s drug price control order, which is vital to the availability of affordable essential medicines, has been whittled down to the point of becoming insignificant. While the number of price-controlled medicines has dwindled over the past three decades, from 347 to 74, the pharmaceutical industry has been pursuing super profits. The High Level Expert Group of the Planning Commission on Universal Health Coverage noted in its report that price variation of therapeutically similar drugs based on brand could be as much as 1,000 per cent in the market; low official procurement prices for similar drugs were found to vary by a staggering 100 to 5,000 per cent in relation to market prices. Given these trends, it is unsurprising that 74 per cent of out-of-pocket spending on health by Indians is towards medicines. The distressing reality is that millions go without medications because they cannot afford them and they are not available free from government facilities. Activists have justifiably sought the intervention of the Supreme Court, and the Centre has the responsibility to act quickly. At this stage, it ill-serves the goal to merely expand the National List of Essential Medicines, without arriving at a rational price control formula. Here, the system of cost-based pricing with provision to add post-manufacturing expenses can be built upon, since ingredient and other costs are transparent under declarations made by producers for taxation purposes.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Direct control of drug prices is unavoidable in India because the option of indirect control at the time of procurement by public health agencies and insurers is not yet available, as in Europe and the U.S. Citizens in developed countries are insulated from the vagaries of market pricing: they either do not pay at the point of treatment or get a cash reimbursement. But even here, there is the Tamil Nadu model &amp;mdash; under which the pharmaceutical industry supplies quality drugs at a fraction of the market price. What this proves is that the price of a drug in the market cannot be several hundred per cent more than what is paid by official agencies. In the sample case of anti-hypertensive drug atenolol, in 2008-09 prices, a strip of tablets was procured officially by Tamil Nadu for Rs.1.20, while consumers bought it for Rs. 26.30 from the market leader. Clearly, the case for reform and cost-based pricing cannot be overstated. The Centre must also plug loopholes that help manufacturers evade price controls by producing combinations of essential and other medications. A panel of professionals to examine all medicines consumed in the country must be constituted, to prepare a more exhaustive and relevant list of essential drugs.&amp;nbsp;&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 18241,
	&#039;title&#039; =&gt; &#039;Growing crisis of drug prices&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div style=&quot;text-align: justify&quot;&gt;
-The Hindu
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
India&amp;rsquo;s drug price control order, which is vital to the availability of affordable essential medicines, has been whittled down to the point of becoming insignificant. While the number of price-controlled medicines has dwindled over the past three decades, from 347 to 74, the pharmaceutical industry has been pursuing super profits. The High Level Expert Group of the Planning Commission on Universal Health Coverage noted in its report that price variation of therapeutically similar drugs based on brand could be as much as 1,000 per cent in the market; low official procurement prices for similar drugs were found to vary by a staggering 100 to 5,000 per cent in relation to market prices. Given these trends, it is unsurprising that 74 per cent of out-of-pocket spending on health by Indians is towards medicines. The distressing reality is that millions go without medications because they cannot afford them and they are not available free from government facilities. Activists have justifiably sought the intervention of the Supreme Court, and the Centre has the responsibility to act quickly. At this stage, it ill-serves the goal to merely expand the National List of Essential Medicines, without arriving at a rational price control formula. Here, the system of cost-based pricing with provision to add post-manufacturing expenses can be built upon, since ingredient and other costs are transparent under declarations made by producers for taxation purposes.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Direct control of drug prices is unavoidable in India because the option of indirect control at the time of procurement by public health agencies and insurers is not yet available, as in Europe and the U.S. Citizens in developed countries are insulated from the vagaries of market pricing: they either do not pay at the point of treatment or get a cash reimbursement. But even here, there is the Tamil Nadu model &amp;mdash; under which the pharmaceutical industry supplies quality drugs at a fraction of the market price. What this proves is that the price of a drug in the market cannot be several hundred per cent more than what is paid by official agencies. In the sample case of anti-hypertensive drug atenolol, in 2008-09 prices, a strip of tablets was procured officially by Tamil Nadu for Rs.1.20, while consumers bought it for Rs. 26.30 from the market leader. Clearly, the case for reform and cost-based pricing cannot be overstated. The Centre must also plug loopholes that help manufacturers evade price controls by producing combinations of essential and other medications. A panel of professionals to examine all medicines consumed in the country must be constituted, to prepare a more exhaustive and relevant list of essential drugs.&amp;nbsp;
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Hindu, 30 November, 2012, http://www.thehindu.com/opinion/editorial/growing-crisis-of-drug-prices/article4147475.ece&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;growing-crisis-of-drug-prices-18370&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 18370,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 18241
$metaTitle = &#039;LATEST NEWS UPDATES | Growing crisis of drug prices&#039;
$metaKeywords = &#039;medicines,Health,Inflation&#039;
$metaDesc = &#039;
-The Hindu





India&amp;rsquo;s drug price control order, which is vital to the availability of affordable essential medicines, has been whittled down to the point of becoming insignificant. While the number of price-controlled medicines has dwindled over the past three decades, from...&#039;
$disp = &#039;&lt;div style=&quot;text-align: justify&quot;&gt;-The Hindu&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;India&amp;rsquo;s drug price control order, which is vital to the availability of affordable essential medicines, has been whittled down to the point of becoming insignificant. While the number of price-controlled medicines has dwindled over the past three decades, from 347 to 74, the pharmaceutical industry has been pursuing super profits. The High Level Expert Group of the Planning Commission on Universal Health Coverage noted in its report that price variation of therapeutically similar drugs based on brand could be as much as 1,000 per cent in the market; low official procurement prices for similar drugs were found to vary by a staggering 100 to 5,000 per cent in relation to market prices. Given these trends, it is unsurprising that 74 per cent of out-of-pocket spending on health by Indians is towards medicines. The distressing reality is that millions go without medications because they cannot afford them and they are not available free from government facilities. Activists have justifiably sought the intervention of the Supreme Court, and the Centre has the responsibility to act quickly. At this stage, it ill-serves the goal to merely expand the National List of Essential Medicines, without arriving at a rational price control formula. Here, the system of cost-based pricing with provision to add post-manufacturing expenses can be built upon, since ingredient and other costs are transparent under declarations made by producers for taxation purposes.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Direct control of drug prices is unavoidable in India because the option of indirect control at the time of procurement by public health agencies and insurers is not yet available, as in Europe and the U.S. Citizens in developed countries are insulated from the vagaries of market pricing: they either do not pay at the point of treatment or get a cash reimbursement. But even here, there is the Tamil Nadu model &amp;mdash; under which the pharmaceutical industry supplies quality drugs at a fraction of the market price. What this proves is that the price of a drug in the market cannot be several hundred per cent more than what is paid by official agencies. In the sample case of anti-hypertensive drug atenolol, in 2008-09 prices, a strip of tablets was procured officially by Tamil Nadu for Rs.1.20, while consumers bought it for Rs. 26.30 from the market leader. Clearly, the case for reform and cost-based pricing cannot be overstated. The Centre must also plug loopholes that help manufacturers evade price controls by producing combinations of essential and other medications. A panel of professionals to examine all medicines consumed in the country must be constituted, to prepare a more exhaustive and relevant list of essential drugs.&amp;nbsp;&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/growing-crisis-of-drug-prices-18370.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Growing crisis of drug prices | Im4change.org</title>
    <meta name="description" content="
-The Hindu





India&rsquo;s drug price control order, which is vital to the availability of affordable essential medicines, has been whittled down to the point of becoming insignificant. While the number of price-controlled medicines has dwindled over the past three decades, from..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Growing crisis of drug prices</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div style="text-align: justify">-The Hindu</div><div style="text-align: justify"><br /></div><div style="text-align: justify">India&rsquo;s drug price control order, which is vital to the availability of affordable essential medicines, has been whittled down to the point of becoming insignificant. While the number of price-controlled medicines has dwindled over the past three decades, from 347 to 74, the pharmaceutical industry has been pursuing super profits. The High Level Expert Group of the Planning Commission on Universal Health Coverage noted in its report that price variation of therapeutically similar drugs based on brand could be as much as 1,000 per cent in the market; low official procurement prices for similar drugs were found to vary by a staggering 100 to 5,000 per cent in relation to market prices. Given these trends, it is unsurprising that 74 per cent of out-of-pocket spending on health by Indians is towards medicines. The distressing reality is that millions go without medications because they cannot afford them and they are not available free from government facilities. Activists have justifiably sought the intervention of the Supreme Court, and the Centre has the responsibility to act quickly. At this stage, it ill-serves the goal to merely expand the National List of Essential Medicines, without arriving at a rational price control formula. Here, the system of cost-based pricing with provision to add post-manufacturing expenses can be built upon, since ingredient and other costs are transparent under declarations made by producers for taxation purposes.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">Direct control of drug prices is unavoidable in India because the option of indirect control at the time of procurement by public health agencies and insurers is not yet available, as in Europe and the U.S. Citizens in developed countries are insulated from the vagaries of market pricing: they either do not pay at the point of treatment or get a cash reimbursement. But even here, there is the Tamil Nadu model &mdash; under which the pharmaceutical industry supplies quality drugs at a fraction of the market price. What this proves is that the price of a drug in the market cannot be several hundred per cent more than what is paid by official agencies. In the sample case of anti-hypertensive drug atenolol, in 2008-09 prices, a strip of tablets was procured officially by Tamil Nadu for Rs.1.20, while consumers bought it for Rs. 26.30 from the market leader. Clearly, the case for reform and cost-based pricing cannot be overstated. The Centre must also plug loopholes that help manufacturers evade price controls by producing combinations of essential and other medications. A panel of professionals to examine all medicines consumed in the country must be constituted, to prepare a more exhaustive and relevant list of essential drugs.&nbsp;</div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$maxBufferLength = (int) 8192
$file = '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php'
$line = (int) 853
$message = 'Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853'
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 48
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]
Code Context
            $response->getStatusCode(),

            ($reasonPhrase ? ' ' . $reasonPhrase : '')

        ));
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f3f8cc71fea-trace').style.display = (document.getElementById('cakeErr67f3f8cc71fea-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f3f8cc71fea-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f3f8cc71fea-code').style.display = (document.getElementById('cakeErr67f3f8cc71fea-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f3f8cc71fea-context').style.display = (document.getElementById('cakeErr67f3f8cc71fea-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f3f8cc71fea-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f3f8cc71fea-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 18241,
		&#039;title&#039; =&gt; &#039;Growing crisis of drug prices&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div style=&quot;text-align: justify&quot;&gt;
-The Hindu
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
India&amp;rsquo;s drug price control order, which is vital to the availability of affordable essential medicines, has been whittled down to the point of becoming insignificant. While the number of price-controlled medicines has dwindled over the past three decades, from 347 to 74, the pharmaceutical industry has been pursuing super profits. The High Level Expert Group of the Planning Commission on Universal Health Coverage noted in its report that price variation of therapeutically similar drugs based on brand could be as much as 1,000 per cent in the market; low official procurement prices for similar drugs were found to vary by a staggering 100 to 5,000 per cent in relation to market prices. Given these trends, it is unsurprising that 74 per cent of out-of-pocket spending on health by Indians is towards medicines. The distressing reality is that millions go without medications because they cannot afford them and they are not available free from government facilities. Activists have justifiably sought the intervention of the Supreme Court, and the Centre has the responsibility to act quickly. At this stage, it ill-serves the goal to merely expand the National List of Essential Medicines, without arriving at a rational price control formula. Here, the system of cost-based pricing with provision to add post-manufacturing expenses can be built upon, since ingredient and other costs are transparent under declarations made by producers for taxation purposes.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Direct control of drug prices is unavoidable in India because the option of indirect control at the time of procurement by public health agencies and insurers is not yet available, as in Europe and the U.S. Citizens in developed countries are insulated from the vagaries of market pricing: they either do not pay at the point of treatment or get a cash reimbursement. But even here, there is the Tamil Nadu model &amp;mdash; under which the pharmaceutical industry supplies quality drugs at a fraction of the market price. What this proves is that the price of a drug in the market cannot be several hundred per cent more than what is paid by official agencies. In the sample case of anti-hypertensive drug atenolol, in 2008-09 prices, a strip of tablets was procured officially by Tamil Nadu for Rs.1.20, while consumers bought it for Rs. 26.30 from the market leader. Clearly, the case for reform and cost-based pricing cannot be overstated. The Centre must also plug loopholes that help manufacturers evade price controls by producing combinations of essential and other medications. A panel of professionals to examine all medicines consumed in the country must be constituted, to prepare a more exhaustive and relevant list of essential drugs.&amp;nbsp;
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Hindu, 30 November, 2012, http://www.thehindu.com/opinion/editorial/growing-crisis-of-drug-prices/article4147475.ece&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;growing-crisis-of-drug-prices-18370&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 18370,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 18241,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Growing crisis of drug prices&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;medicines,Health,Inflation&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Hindu





India&amp;rsquo;s drug price control order, which is vital to the availability of affordable essential medicines, has been whittled down to the point of becoming insignificant. While the number of price-controlled medicines has dwindled over the past three decades, from...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div style=&quot;text-align: justify&quot;&gt;-The Hindu&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;India&amp;rsquo;s drug price control order, which is vital to the availability of affordable essential medicines, has been whittled down to the point of becoming insignificant. While the number of price-controlled medicines has dwindled over the past three decades, from 347 to 74, the pharmaceutical industry has been pursuing super profits. The High Level Expert Group of the Planning Commission on Universal Health Coverage noted in its report that price variation of therapeutically similar drugs based on brand could be as much as 1,000 per cent in the market; low official procurement prices for similar drugs were found to vary by a staggering 100 to 5,000 per cent in relation to market prices. Given these trends, it is unsurprising that 74 per cent of out-of-pocket spending on health by Indians is towards medicines. The distressing reality is that millions go without medications because they cannot afford them and they are not available free from government facilities. Activists have justifiably sought the intervention of the Supreme Court, and the Centre has the responsibility to act quickly. At this stage, it ill-serves the goal to merely expand the National List of Essential Medicines, without arriving at a rational price control formula. Here, the system of cost-based pricing with provision to add post-manufacturing expenses can be built upon, since ingredient and other costs are transparent under declarations made by producers for taxation purposes.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Direct control of drug prices is unavoidable in India because the option of indirect control at the time of procurement by public health agencies and insurers is not yet available, as in Europe and the U.S. Citizens in developed countries are insulated from the vagaries of market pricing: they either do not pay at the point of treatment or get a cash reimbursement. But even here, there is the Tamil Nadu model &amp;mdash; under which the pharmaceutical industry supplies quality drugs at a fraction of the market price. What this proves is that the price of a drug in the market cannot be several hundred per cent more than what is paid by official agencies. In the sample case of anti-hypertensive drug atenolol, in 2008-09 prices, a strip of tablets was procured officially by Tamil Nadu for Rs.1.20, while consumers bought it for Rs. 26.30 from the market leader. Clearly, the case for reform and cost-based pricing cannot be overstated. The Centre must also plug loopholes that help manufacturers evade price controls by producing combinations of essential and other medications. A panel of professionals to examine all medicines consumed in the country must be constituted, to prepare a more exhaustive and relevant list of essential drugs.&amp;nbsp;&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 18241,
	&#039;title&#039; =&gt; &#039;Growing crisis of drug prices&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div style=&quot;text-align: justify&quot;&gt;
-The Hindu
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
India&amp;rsquo;s drug price control order, which is vital to the availability of affordable essential medicines, has been whittled down to the point of becoming insignificant. While the number of price-controlled medicines has dwindled over the past three decades, from 347 to 74, the pharmaceutical industry has been pursuing super profits. The High Level Expert Group of the Planning Commission on Universal Health Coverage noted in its report that price variation of therapeutically similar drugs based on brand could be as much as 1,000 per cent in the market; low official procurement prices for similar drugs were found to vary by a staggering 100 to 5,000 per cent in relation to market prices. Given these trends, it is unsurprising that 74 per cent of out-of-pocket spending on health by Indians is towards medicines. The distressing reality is that millions go without medications because they cannot afford them and they are not available free from government facilities. Activists have justifiably sought the intervention of the Supreme Court, and the Centre has the responsibility to act quickly. At this stage, it ill-serves the goal to merely expand the National List of Essential Medicines, without arriving at a rational price control formula. Here, the system of cost-based pricing with provision to add post-manufacturing expenses can be built upon, since ingredient and other costs are transparent under declarations made by producers for taxation purposes.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Direct control of drug prices is unavoidable in India because the option of indirect control at the time of procurement by public health agencies and insurers is not yet available, as in Europe and the U.S. Citizens in developed countries are insulated from the vagaries of market pricing: they either do not pay at the point of treatment or get a cash reimbursement. But even here, there is the Tamil Nadu model &amp;mdash; under which the pharmaceutical industry supplies quality drugs at a fraction of the market price. What this proves is that the price of a drug in the market cannot be several hundred per cent more than what is paid by official agencies. In the sample case of anti-hypertensive drug atenolol, in 2008-09 prices, a strip of tablets was procured officially by Tamil Nadu for Rs.1.20, while consumers bought it for Rs. 26.30 from the market leader. Clearly, the case for reform and cost-based pricing cannot be overstated. The Centre must also plug loopholes that help manufacturers evade price controls by producing combinations of essential and other medications. A panel of professionals to examine all medicines consumed in the country must be constituted, to prepare a more exhaustive and relevant list of essential drugs.&amp;nbsp;
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Hindu, 30 November, 2012, http://www.thehindu.com/opinion/editorial/growing-crisis-of-drug-prices/article4147475.ece&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;growing-crisis-of-drug-prices-18370&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 18370,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 18241
$metaTitle = &#039;LATEST NEWS UPDATES | Growing crisis of drug prices&#039;
$metaKeywords = &#039;medicines,Health,Inflation&#039;
$metaDesc = &#039;
-The Hindu





India&amp;rsquo;s drug price control order, which is vital to the availability of affordable essential medicines, has been whittled down to the point of becoming insignificant. While the number of price-controlled medicines has dwindled over the past three decades, from...&#039;
$disp = &#039;&lt;div style=&quot;text-align: justify&quot;&gt;-The Hindu&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;India&amp;rsquo;s drug price control order, which is vital to the availability of affordable essential medicines, has been whittled down to the point of becoming insignificant. While the number of price-controlled medicines has dwindled over the past three decades, from 347 to 74, the pharmaceutical industry has been pursuing super profits. The High Level Expert Group of the Planning Commission on Universal Health Coverage noted in its report that price variation of therapeutically similar drugs based on brand could be as much as 1,000 per cent in the market; low official procurement prices for similar drugs were found to vary by a staggering 100 to 5,000 per cent in relation to market prices. Given these trends, it is unsurprising that 74 per cent of out-of-pocket spending on health by Indians is towards medicines. The distressing reality is that millions go without medications because they cannot afford them and they are not available free from government facilities. Activists have justifiably sought the intervention of the Supreme Court, and the Centre has the responsibility to act quickly. At this stage, it ill-serves the goal to merely expand the National List of Essential Medicines, without arriving at a rational price control formula. Here, the system of cost-based pricing with provision to add post-manufacturing expenses can be built upon, since ingredient and other costs are transparent under declarations made by producers for taxation purposes.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Direct control of drug prices is unavoidable in India because the option of indirect control at the time of procurement by public health agencies and insurers is not yet available, as in Europe and the U.S. Citizens in developed countries are insulated from the vagaries of market pricing: they either do not pay at the point of treatment or get a cash reimbursement. But even here, there is the Tamil Nadu model &amp;mdash; under which the pharmaceutical industry supplies quality drugs at a fraction of the market price. What this proves is that the price of a drug in the market cannot be several hundred per cent more than what is paid by official agencies. In the sample case of anti-hypertensive drug atenolol, in 2008-09 prices, a strip of tablets was procured officially by Tamil Nadu for Rs.1.20, while consumers bought it for Rs. 26.30 from the market leader. Clearly, the case for reform and cost-based pricing cannot be overstated. The Centre must also plug loopholes that help manufacturers evade price controls by producing combinations of essential and other medications. A panel of professionals to examine all medicines consumed in the country must be constituted, to prepare a more exhaustive and relevant list of essential drugs.&amp;nbsp;&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/growing-crisis-of-drug-prices-18370.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Growing crisis of drug prices | Im4change.org</title>
    <meta name="description" content="
-The Hindu





India&rsquo;s drug price control order, which is vital to the availability of affordable essential medicines, has been whittled down to the point of becoming insignificant. While the number of price-controlled medicines has dwindled over the past three decades, from..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Growing crisis of drug prices</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div style="text-align: justify">-The Hindu</div><div style="text-align: justify"><br /></div><div style="text-align: justify">India&rsquo;s drug price control order, which is vital to the availability of affordable essential medicines, has been whittled down to the point of becoming insignificant. While the number of price-controlled medicines has dwindled over the past three decades, from 347 to 74, the pharmaceutical industry has been pursuing super profits. The High Level Expert Group of the Planning Commission on Universal Health Coverage noted in its report that price variation of therapeutically similar drugs based on brand could be as much as 1,000 per cent in the market; low official procurement prices for similar drugs were found to vary by a staggering 100 to 5,000 per cent in relation to market prices. Given these trends, it is unsurprising that 74 per cent of out-of-pocket spending on health by Indians is towards medicines. The distressing reality is that millions go without medications because they cannot afford them and they are not available free from government facilities. Activists have justifiably sought the intervention of the Supreme Court, and the Centre has the responsibility to act quickly. At this stage, it ill-serves the goal to merely expand the National List of Essential Medicines, without arriving at a rational price control formula. Here, the system of cost-based pricing with provision to add post-manufacturing expenses can be built upon, since ingredient and other costs are transparent under declarations made by producers for taxation purposes.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">Direct control of drug prices is unavoidable in India because the option of indirect control at the time of procurement by public health agencies and insurers is not yet available, as in Europe and the U.S. Citizens in developed countries are insulated from the vagaries of market pricing: they either do not pay at the point of treatment or get a cash reimbursement. But even here, there is the Tamil Nadu model &mdash; under which the pharmaceutical industry supplies quality drugs at a fraction of the market price. What this proves is that the price of a drug in the market cannot be several hundred per cent more than what is paid by official agencies. In the sample case of anti-hypertensive drug atenolol, in 2008-09 prices, a strip of tablets was procured officially by Tamil Nadu for Rs.1.20, while consumers bought it for Rs. 26.30 from the market leader. Clearly, the case for reform and cost-based pricing cannot be overstated. The Centre must also plug loopholes that help manufacturers evade price controls by producing combinations of essential and other medications. A panel of professionals to examine all medicines consumed in the country must be constituted, to prepare a more exhaustive and relevant list of essential drugs.&nbsp;</div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$reasonPhrase = 'OK'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitStatusLine() - CORE/src/Http/ResponseEmitter.php, line 148
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 54
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]
Code Context
                    $value

                ), $first);

                $first = false;
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f3f8cc71fea-trace').style.display = (document.getElementById('cakeErr67f3f8cc71fea-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f3f8cc71fea-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f3f8cc71fea-code').style.display = (document.getElementById('cakeErr67f3f8cc71fea-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f3f8cc71fea-context').style.display = (document.getElementById('cakeErr67f3f8cc71fea-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f3f8cc71fea-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f3f8cc71fea-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 18241,
		&#039;title&#039; =&gt; &#039;Growing crisis of drug prices&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div style=&quot;text-align: justify&quot;&gt;
-The Hindu
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
India&amp;rsquo;s drug price control order, which is vital to the availability of affordable essential medicines, has been whittled down to the point of becoming insignificant. While the number of price-controlled medicines has dwindled over the past three decades, from 347 to 74, the pharmaceutical industry has been pursuing super profits. The High Level Expert Group of the Planning Commission on Universal Health Coverage noted in its report that price variation of therapeutically similar drugs based on brand could be as much as 1,000 per cent in the market; low official procurement prices for similar drugs were found to vary by a staggering 100 to 5,000 per cent in relation to market prices. Given these trends, it is unsurprising that 74 per cent of out-of-pocket spending on health by Indians is towards medicines. The distressing reality is that millions go without medications because they cannot afford them and they are not available free from government facilities. Activists have justifiably sought the intervention of the Supreme Court, and the Centre has the responsibility to act quickly. At this stage, it ill-serves the goal to merely expand the National List of Essential Medicines, without arriving at a rational price control formula. Here, the system of cost-based pricing with provision to add post-manufacturing expenses can be built upon, since ingredient and other costs are transparent under declarations made by producers for taxation purposes.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Direct control of drug prices is unavoidable in India because the option of indirect control at the time of procurement by public health agencies and insurers is not yet available, as in Europe and the U.S. Citizens in developed countries are insulated from the vagaries of market pricing: they either do not pay at the point of treatment or get a cash reimbursement. But even here, there is the Tamil Nadu model &amp;mdash; under which the pharmaceutical industry supplies quality drugs at a fraction of the market price. What this proves is that the price of a drug in the market cannot be several hundred per cent more than what is paid by official agencies. In the sample case of anti-hypertensive drug atenolol, in 2008-09 prices, a strip of tablets was procured officially by Tamil Nadu for Rs.1.20, while consumers bought it for Rs. 26.30 from the market leader. Clearly, the case for reform and cost-based pricing cannot be overstated. The Centre must also plug loopholes that help manufacturers evade price controls by producing combinations of essential and other medications. A panel of professionals to examine all medicines consumed in the country must be constituted, to prepare a more exhaustive and relevant list of essential drugs.&amp;nbsp;
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Hindu, 30 November, 2012, http://www.thehindu.com/opinion/editorial/growing-crisis-of-drug-prices/article4147475.ece&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;growing-crisis-of-drug-prices-18370&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 18370,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 18241,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Growing crisis of drug prices&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;medicines,Health,Inflation&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Hindu





India&amp;rsquo;s drug price control order, which is vital to the availability of affordable essential medicines, has been whittled down to the point of becoming insignificant. While the number of price-controlled medicines has dwindled over the past three decades, from...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div style=&quot;text-align: justify&quot;&gt;-The Hindu&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;India&amp;rsquo;s drug price control order, which is vital to the availability of affordable essential medicines, has been whittled down to the point of becoming insignificant. While the number of price-controlled medicines has dwindled over the past three decades, from 347 to 74, the pharmaceutical industry has been pursuing super profits. The High Level Expert Group of the Planning Commission on Universal Health Coverage noted in its report that price variation of therapeutically similar drugs based on brand could be as much as 1,000 per cent in the market; low official procurement prices for similar drugs were found to vary by a staggering 100 to 5,000 per cent in relation to market prices. Given these trends, it is unsurprising that 74 per cent of out-of-pocket spending on health by Indians is towards medicines. The distressing reality is that millions go without medications because they cannot afford them and they are not available free from government facilities. Activists have justifiably sought the intervention of the Supreme Court, and the Centre has the responsibility to act quickly. At this stage, it ill-serves the goal to merely expand the National List of Essential Medicines, without arriving at a rational price control formula. Here, the system of cost-based pricing with provision to add post-manufacturing expenses can be built upon, since ingredient and other costs are transparent under declarations made by producers for taxation purposes.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Direct control of drug prices is unavoidable in India because the option of indirect control at the time of procurement by public health agencies and insurers is not yet available, as in Europe and the U.S. Citizens in developed countries are insulated from the vagaries of market pricing: they either do not pay at the point of treatment or get a cash reimbursement. But even here, there is the Tamil Nadu model &amp;mdash; under which the pharmaceutical industry supplies quality drugs at a fraction of the market price. What this proves is that the price of a drug in the market cannot be several hundred per cent more than what is paid by official agencies. In the sample case of anti-hypertensive drug atenolol, in 2008-09 prices, a strip of tablets was procured officially by Tamil Nadu for Rs.1.20, while consumers bought it for Rs. 26.30 from the market leader. Clearly, the case for reform and cost-based pricing cannot be overstated. The Centre must also plug loopholes that help manufacturers evade price controls by producing combinations of essential and other medications. A panel of professionals to examine all medicines consumed in the country must be constituted, to prepare a more exhaustive and relevant list of essential drugs.&amp;nbsp;&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 18241,
	&#039;title&#039; =&gt; &#039;Growing crisis of drug prices&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div style=&quot;text-align: justify&quot;&gt;
-The Hindu
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
India&amp;rsquo;s drug price control order, which is vital to the availability of affordable essential medicines, has been whittled down to the point of becoming insignificant. While the number of price-controlled medicines has dwindled over the past three decades, from 347 to 74, the pharmaceutical industry has been pursuing super profits. The High Level Expert Group of the Planning Commission on Universal Health Coverage noted in its report that price variation of therapeutically similar drugs based on brand could be as much as 1,000 per cent in the market; low official procurement prices for similar drugs were found to vary by a staggering 100 to 5,000 per cent in relation to market prices. Given these trends, it is unsurprising that 74 per cent of out-of-pocket spending on health by Indians is towards medicines. The distressing reality is that millions go without medications because they cannot afford them and they are not available free from government facilities. Activists have justifiably sought the intervention of the Supreme Court, and the Centre has the responsibility to act quickly. At this stage, it ill-serves the goal to merely expand the National List of Essential Medicines, without arriving at a rational price control formula. Here, the system of cost-based pricing with provision to add post-manufacturing expenses can be built upon, since ingredient and other costs are transparent under declarations made by producers for taxation purposes.
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
&lt;br /&gt;
&lt;/div&gt;
&lt;div style=&quot;text-align: justify&quot;&gt;
Direct control of drug prices is unavoidable in India because the option of indirect control at the time of procurement by public health agencies and insurers is not yet available, as in Europe and the U.S. Citizens in developed countries are insulated from the vagaries of market pricing: they either do not pay at the point of treatment or get a cash reimbursement. But even here, there is the Tamil Nadu model &amp;mdash; under which the pharmaceutical industry supplies quality drugs at a fraction of the market price. What this proves is that the price of a drug in the market cannot be several hundred per cent more than what is paid by official agencies. In the sample case of anti-hypertensive drug atenolol, in 2008-09 prices, a strip of tablets was procured officially by Tamil Nadu for Rs.1.20, while consumers bought it for Rs. 26.30 from the market leader. Clearly, the case for reform and cost-based pricing cannot be overstated. The Centre must also plug loopholes that help manufacturers evade price controls by producing combinations of essential and other medications. A panel of professionals to examine all medicines consumed in the country must be constituted, to prepare a more exhaustive and relevant list of essential drugs.&amp;nbsp;
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Hindu, 30 November, 2012, http://www.thehindu.com/opinion/editorial/growing-crisis-of-drug-prices/article4147475.ece&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;growing-crisis-of-drug-prices-18370&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 18370,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 18241
$metaTitle = &#039;LATEST NEWS UPDATES | Growing crisis of drug prices&#039;
$metaKeywords = &#039;medicines,Health,Inflation&#039;
$metaDesc = &#039;
-The Hindu





India&amp;rsquo;s drug price control order, which is vital to the availability of affordable essential medicines, has been whittled down to the point of becoming insignificant. While the number of price-controlled medicines has dwindled over the past three decades, from...&#039;
$disp = &#039;&lt;div style=&quot;text-align: justify&quot;&gt;-The Hindu&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;India&amp;rsquo;s drug price control order, which is vital to the availability of affordable essential medicines, has been whittled down to the point of becoming insignificant. While the number of price-controlled medicines has dwindled over the past three decades, from 347 to 74, the pharmaceutical industry has been pursuing super profits. The High Level Expert Group of the Planning Commission on Universal Health Coverage noted in its report that price variation of therapeutically similar drugs based on brand could be as much as 1,000 per cent in the market; low official procurement prices for similar drugs were found to vary by a staggering 100 to 5,000 per cent in relation to market prices. Given these trends, it is unsurprising that 74 per cent of out-of-pocket spending on health by Indians is towards medicines. The distressing reality is that millions go without medications because they cannot afford them and they are not available free from government facilities. Activists have justifiably sought the intervention of the Supreme Court, and the Centre has the responsibility to act quickly. At this stage, it ill-serves the goal to merely expand the National List of Essential Medicines, without arriving at a rational price control formula. Here, the system of cost-based pricing with provision to add post-manufacturing expenses can be built upon, since ingredient and other costs are transparent under declarations made by producers for taxation purposes.&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style=&quot;text-align: justify&quot;&gt;Direct control of drug prices is unavoidable in India because the option of indirect control at the time of procurement by public health agencies and insurers is not yet available, as in Europe and the U.S. Citizens in developed countries are insulated from the vagaries of market pricing: they either do not pay at the point of treatment or get a cash reimbursement. But even here, there is the Tamil Nadu model &amp;mdash; under which the pharmaceutical industry supplies quality drugs at a fraction of the market price. What this proves is that the price of a drug in the market cannot be several hundred per cent more than what is paid by official agencies. In the sample case of anti-hypertensive drug atenolol, in 2008-09 prices, a strip of tablets was procured officially by Tamil Nadu for Rs.1.20, while consumers bought it for Rs. 26.30 from the market leader. Clearly, the case for reform and cost-based pricing cannot be overstated. The Centre must also plug loopholes that help manufacturers evade price controls by producing combinations of essential and other medications. A panel of professionals to examine all medicines consumed in the country must be constituted, to prepare a more exhaustive and relevant list of essential drugs.&amp;nbsp;&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/growing-crisis-of-drug-prices-18370.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Growing crisis of drug prices | Im4change.org</title>
    <meta name="description" content="
-The Hindu





India&rsquo;s drug price control order, which is vital to the availability of affordable essential medicines, has been whittled down to the point of becoming insignificant. While the number of price-controlled medicines has dwindled over the past three decades, from..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Growing crisis of drug prices</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div style="text-align: justify">-The Hindu</div><div style="text-align: justify"><br /></div><div style="text-align: justify">India&rsquo;s drug price control order, which is vital to the availability of affordable essential medicines, has been whittled down to the point of becoming insignificant. While the number of price-controlled medicines has dwindled over the past three decades, from 347 to 74, the pharmaceutical industry has been pursuing super profits. The High Level Expert Group of the Planning Commission on Universal Health Coverage noted in its report that price variation of therapeutically similar drugs based on brand could be as much as 1,000 per cent in the market; low official procurement prices for similar drugs were found to vary by a staggering 100 to 5,000 per cent in relation to market prices. Given these trends, it is unsurprising that 74 per cent of out-of-pocket spending on health by Indians is towards medicines. The distressing reality is that millions go without medications because they cannot afford them and they are not available free from government facilities. Activists have justifiably sought the intervention of the Supreme Court, and the Centre has the responsibility to act quickly. At this stage, it ill-serves the goal to merely expand the National List of Essential Medicines, without arriving at a rational price control formula. Here, the system of cost-based pricing with provision to add post-manufacturing expenses can be built upon, since ingredient and other costs are transparent under declarations made by producers for taxation purposes.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">Direct control of drug prices is unavoidable in India because the option of indirect control at the time of procurement by public health agencies and insurers is not yet available, as in Europe and the U.S. Citizens in developed countries are insulated from the vagaries of market pricing: they either do not pay at the point of treatment or get a cash reimbursement. But even here, there is the Tamil Nadu model &mdash; under which the pharmaceutical industry supplies quality drugs at a fraction of the market price. What this proves is that the price of a drug in the market cannot be several hundred per cent more than what is paid by official agencies. In the sample case of anti-hypertensive drug atenolol, in 2008-09 prices, a strip of tablets was procured officially by Tamil Nadu for Rs.1.20, while consumers bought it for Rs. 26.30 from the market leader. Clearly, the case for reform and cost-based pricing cannot be overstated. The Centre must also plug loopholes that help manufacturers evade price controls by producing combinations of essential and other medications. A panel of professionals to examine all medicines consumed in the country must be constituted, to prepare a more exhaustive and relevant list of essential drugs.&nbsp;</div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$cookies = []
$values = [
	(int) 0 => 'text/html; charset=UTF-8'
]
$name = 'Content-Type'
$first = true
$value = 'text/html; charset=UTF-8'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitHeaders() - CORE/src/Http/ResponseEmitter.php, line 181
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 55
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

<head>

    <link rel="canonical" href="<?php echo Configure::read('SITE_URL'); ?><?php echo $urlPrefix;?><?php echo $article_current->category->slug; ?>/<?php echo $article_current->seo_url; ?>.html"/>

    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>

$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp'
$dataForView = [
	'article_current' => object(App\Model\Entity\Article) {

		'id' => (int) 18241,
		'title' => 'Growing crisis of drug prices',
		'subheading' => '',
		'description' => '<div style="text-align: justify">
-The Hindu
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
India&rsquo;s drug price control order, which is vital to the availability of affordable essential medicines, has been whittled down to the point of becoming insignificant. While the number of price-controlled medicines has dwindled over the past three decades, from 347 to 74, the pharmaceutical industry has been pursuing super profits. The High Level Expert Group of the Planning Commission on Universal Health Coverage noted in its report that price variation of therapeutically similar drugs based on brand could be as much as 1,000 per cent in the market; low official procurement prices for similar drugs were found to vary by a staggering 100 to 5,000 per cent in relation to market prices. Given these trends, it is unsurprising that 74 per cent of out-of-pocket spending on health by Indians is towards medicines. The distressing reality is that millions go without medications because they cannot afford them and they are not available free from government facilities. Activists have justifiably sought the intervention of the Supreme Court, and the Centre has the responsibility to act quickly. At this stage, it ill-serves the goal to merely expand the National List of Essential Medicines, without arriving at a rational price control formula. Here, the system of cost-based pricing with provision to add post-manufacturing expenses can be built upon, since ingredient and other costs are transparent under declarations made by producers for taxation purposes.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
Direct control of drug prices is unavoidable in India because the option of indirect control at the time of procurement by public health agencies and insurers is not yet available, as in Europe and the U.S. Citizens in developed countries are insulated from the vagaries of market pricing: they either do not pay at the point of treatment or get a cash reimbursement. But even here, there is the Tamil Nadu model &mdash; under which the pharmaceutical industry supplies quality drugs at a fraction of the market price. What this proves is that the price of a drug in the market cannot be several hundred per cent more than what is paid by official agencies. In the sample case of anti-hypertensive drug atenolol, in 2008-09 prices, a strip of tablets was procured officially by Tamil Nadu for Rs.1.20, while consumers bought it for Rs. 26.30 from the market leader. Clearly, the case for reform and cost-based pricing cannot be overstated. The Centre must also plug loopholes that help manufacturers evade price controls by producing combinations of essential and other medications. A panel of professionals to examine all medicines consumed in the country must be constituted, to prepare a more exhaustive and relevant list of essential drugs.&nbsp;
</div>',
		'credit_writer' => 'The Hindu, 30 November, 2012, http://www.thehindu.com/opinion/editorial/growing-crisis-of-drug-prices/article4147475.ece',
		'article_img' => '',
		'article_img_thumb' => '',
		'status' => (int) 1,
		'show_on_home' => (int) 1,
		'lang' => 'EN',
		'category_id' => (int) 16,
		'tag_keyword' => '',
		'seo_url' => 'growing-crisis-of-drug-prices-18370',
		'meta_title' => null,
		'meta_keywords' => null,
		'meta_description' => null,
		'noindex' => (int) 0,
		'publish_date' => object(Cake\I18n\FrozenDate) {},
		'most_visit_section_id' => null,
		'article_big_img' => null,
		'liveid' => (int) 18370,
		'created' => object(Cake\I18n\FrozenTime) {},
		'modified' => object(Cake\I18n\FrozenTime) {},
		'edate' => '',
		'tags' => [
			[maximum depth reached]
		],
		'category' => object(App\Model\Entity\Category) {},
		'[new]' => false,
		'[accessible]' => [
			[maximum depth reached]
		],
		'[dirty]' => [[maximum depth reached]],
		'[original]' => [[maximum depth reached]],
		'[virtual]' => [[maximum depth reached]],
		'[hasErrors]' => false,
		'[errors]' => [[maximum depth reached]],
		'[invalid]' => [[maximum depth reached]],
		'[repository]' => 'Articles'
	
	},
	'articleid' => (int) 18241,
	'metaTitle' => 'LATEST NEWS UPDATES | Growing crisis of drug prices',
	'metaKeywords' => 'medicines,Health,Inflation',
	'metaDesc' => '
-The Hindu





India&rsquo;s drug price control order, which is vital to the availability of affordable essential medicines, has been whittled down to the point of becoming insignificant. While the number of price-controlled medicines has dwindled over the past three decades, from...',
	'disp' => '<div style="text-align: justify">-The Hindu</div><div style="text-align: justify"><br /></div><div style="text-align: justify">India&rsquo;s drug price control order, which is vital to the availability of affordable essential medicines, has been whittled down to the point of becoming insignificant. While the number of price-controlled medicines has dwindled over the past three decades, from 347 to 74, the pharmaceutical industry has been pursuing super profits. The High Level Expert Group of the Planning Commission on Universal Health Coverage noted in its report that price variation of therapeutically similar drugs based on brand could be as much as 1,000 per cent in the market; low official procurement prices for similar drugs were found to vary by a staggering 100 to 5,000 per cent in relation to market prices. Given these trends, it is unsurprising that 74 per cent of out-of-pocket spending on health by Indians is towards medicines. The distressing reality is that millions go without medications because they cannot afford them and they are not available free from government facilities. Activists have justifiably sought the intervention of the Supreme Court, and the Centre has the responsibility to act quickly. At this stage, it ill-serves the goal to merely expand the National List of Essential Medicines, without arriving at a rational price control formula. Here, the system of cost-based pricing with provision to add post-manufacturing expenses can be built upon, since ingredient and other costs are transparent under declarations made by producers for taxation purposes.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">Direct control of drug prices is unavoidable in India because the option of indirect control at the time of procurement by public health agencies and insurers is not yet available, as in Europe and the U.S. Citizens in developed countries are insulated from the vagaries of market pricing: they either do not pay at the point of treatment or get a cash reimbursement. But even here, there is the Tamil Nadu model &mdash; under which the pharmaceutical industry supplies quality drugs at a fraction of the market price. What this proves is that the price of a drug in the market cannot be several hundred per cent more than what is paid by official agencies. In the sample case of anti-hypertensive drug atenolol, in 2008-09 prices, a strip of tablets was procured officially by Tamil Nadu for Rs.1.20, while consumers bought it for Rs. 26.30 from the market leader. Clearly, the case for reform and cost-based pricing cannot be overstated. The Centre must also plug loopholes that help manufacturers evade price controls by producing combinations of essential and other medications. A panel of professionals to examine all medicines consumed in the country must be constituted, to prepare a more exhaustive and relevant list of essential drugs.&nbsp;</div>',
	'lang' => 'English',
	'SITE_URL' => 'https://im4change.in/',
	'site_title' => 'im4change',
	'adminprix' => 'admin'
]
$article_current = object(App\Model\Entity\Article) {

	'id' => (int) 18241,
	'title' => 'Growing crisis of drug prices',
	'subheading' => '',
	'description' => '<div style="text-align: justify">
-The Hindu
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
India&rsquo;s drug price control order, which is vital to the availability of affordable essential medicines, has been whittled down to the point of becoming insignificant. While the number of price-controlled medicines has dwindled over the past three decades, from 347 to 74, the pharmaceutical industry has been pursuing super profits. The High Level Expert Group of the Planning Commission on Universal Health Coverage noted in its report that price variation of therapeutically similar drugs based on brand could be as much as 1,000 per cent in the market; low official procurement prices for similar drugs were found to vary by a staggering 100 to 5,000 per cent in relation to market prices. Given these trends, it is unsurprising that 74 per cent of out-of-pocket spending on health by Indians is towards medicines. The distressing reality is that millions go without medications because they cannot afford them and they are not available free from government facilities. Activists have justifiably sought the intervention of the Supreme Court, and the Centre has the responsibility to act quickly. At this stage, it ill-serves the goal to merely expand the National List of Essential Medicines, without arriving at a rational price control formula. Here, the system of cost-based pricing with provision to add post-manufacturing expenses can be built upon, since ingredient and other costs are transparent under declarations made by producers for taxation purposes.
</div>
<div style="text-align: justify">
<br />
</div>
<div style="text-align: justify">
Direct control of drug prices is unavoidable in India because the option of indirect control at the time of procurement by public health agencies and insurers is not yet available, as in Europe and the U.S. Citizens in developed countries are insulated from the vagaries of market pricing: they either do not pay at the point of treatment or get a cash reimbursement. But even here, there is the Tamil Nadu model &mdash; under which the pharmaceutical industry supplies quality drugs at a fraction of the market price. What this proves is that the price of a drug in the market cannot be several hundred per cent more than what is paid by official agencies. In the sample case of anti-hypertensive drug atenolol, in 2008-09 prices, a strip of tablets was procured officially by Tamil Nadu for Rs.1.20, while consumers bought it for Rs. 26.30 from the market leader. Clearly, the case for reform and cost-based pricing cannot be overstated. The Centre must also plug loopholes that help manufacturers evade price controls by producing combinations of essential and other medications. A panel of professionals to examine all medicines consumed in the country must be constituted, to prepare a more exhaustive and relevant list of essential drugs.&nbsp;
</div>',
	'credit_writer' => 'The Hindu, 30 November, 2012, http://www.thehindu.com/opinion/editorial/growing-crisis-of-drug-prices/article4147475.ece',
	'article_img' => '',
	'article_img_thumb' => '',
	'status' => (int) 1,
	'show_on_home' => (int) 1,
	'lang' => 'EN',
	'category_id' => (int) 16,
	'tag_keyword' => '',
	'seo_url' => 'growing-crisis-of-drug-prices-18370',
	'meta_title' => null,
	'meta_keywords' => null,
	'meta_description' => null,
	'noindex' => (int) 0,
	'publish_date' => object(Cake\I18n\FrozenDate) {},
	'most_visit_section_id' => null,
	'article_big_img' => null,
	'liveid' => (int) 18370,
	'created' => object(Cake\I18n\FrozenTime) {},
	'modified' => object(Cake\I18n\FrozenTime) {},
	'edate' => '',
	'tags' => [
		(int) 0 => object(Cake\ORM\Entity) {},
		(int) 1 => object(Cake\ORM\Entity) {},
		(int) 2 => object(Cake\ORM\Entity) {}
	],
	'category' => object(App\Model\Entity\Category) {},
	'[new]' => false,
	'[accessible]' => [
		'*' => true,
		'id' => false
	],
	'[dirty]' => [],
	'[original]' => [],
	'[virtual]' => [],
	'[hasErrors]' => false,
	'[errors]' => [],
	'[invalid]' => [],
	'[repository]' => 'Articles'

}
$articleid = (int) 18241
$metaTitle = 'LATEST NEWS UPDATES | Growing crisis of drug prices'
$metaKeywords = 'medicines,Health,Inflation'
$metaDesc = '
-The Hindu





India&rsquo;s drug price control order, which is vital to the availability of affordable essential medicines, has been whittled down to the point of becoming insignificant. While the number of price-controlled medicines has dwindled over the past three decades, from...'
$disp = '<div style="text-align: justify">-The Hindu</div><div style="text-align: justify"><br /></div><div style="text-align: justify">India&rsquo;s drug price control order, which is vital to the availability of affordable essential medicines, has been whittled down to the point of becoming insignificant. While the number of price-controlled medicines has dwindled over the past three decades, from 347 to 74, the pharmaceutical industry has been pursuing super profits. The High Level Expert Group of the Planning Commission on Universal Health Coverage noted in its report that price variation of therapeutically similar drugs based on brand could be as much as 1,000 per cent in the market; low official procurement prices for similar drugs were found to vary by a staggering 100 to 5,000 per cent in relation to market prices. Given these trends, it is unsurprising that 74 per cent of out-of-pocket spending on health by Indians is towards medicines. The distressing reality is that millions go without medications because they cannot afford them and they are not available free from government facilities. Activists have justifiably sought the intervention of the Supreme Court, and the Centre has the responsibility to act quickly. At this stage, it ill-serves the goal to merely expand the National List of Essential Medicines, without arriving at a rational price control formula. Here, the system of cost-based pricing with provision to add post-manufacturing expenses can be built upon, since ingredient and other costs are transparent under declarations made by producers for taxation purposes.</div><div style="text-align: justify"><br /></div><div style="text-align: justify">Direct control of drug prices is unavoidable in India because the option of indirect control at the time of procurement by public health agencies and insurers is not yet available, as in Europe and the U.S. Citizens in developed countries are insulated from the vagaries of market pricing: they either do not pay at the point of treatment or get a cash reimbursement. But even here, there is the Tamil Nadu model &mdash; under which the pharmaceutical industry supplies quality drugs at a fraction of the market price. What this proves is that the price of a drug in the market cannot be several hundred per cent more than what is paid by official agencies. In the sample case of anti-hypertensive drug atenolol, in 2008-09 prices, a strip of tablets was procured officially by Tamil Nadu for Rs.1.20, while consumers bought it for Rs. 26.30 from the market leader. Clearly, the case for reform and cost-based pricing cannot be overstated. The Centre must also plug loopholes that help manufacturers evade price controls by producing combinations of essential and other medications. A panel of professionals to examine all medicines consumed in the country must be constituted, to prepare a more exhaustive and relevant list of essential drugs.&nbsp;</div>'
$lang = 'English'
$SITE_URL = 'https://im4change.in/'
$site_title = 'im4change'
$adminprix = 'admin'

include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51

Growing crisis of drug prices

-The Hindu India’s drug price control order, which is vital to the availability of affordable essential medicines, has been whittled down to the point of becoming insignificant. While the number of price-controlled medicines has dwindled over the past three decades, from 347 to 74, the pharmaceutical industry has been pursuing super profits. The High Level Expert Group of the Planning Commission on Universal Health Coverage noted in its report that price variation of therapeutically similar drugs based on brand could be as much as 1,000 per cent in the market; low official procurement prices for similar drugs were found to vary by a staggering 100 to 5,000 per cent in relation to market prices. Given these trends, it is unsurprising that 74 per cent of out-of-pocket spending on health by Indians is towards medicines. The distressing reality is that millions go without medications because they cannot afford them and they are not available free from government facilities. Activists have justifiably sought the intervention of the Supreme Court, and the Centre has the responsibility to act quickly. At this stage, it ill-serves the goal to merely expand the National List of Essential Medicines, without arriving at a rational price control formula. Here, the system of cost-based pricing with provision to add post-manufacturing expenses can be built upon, since ingredient and other costs are transparent under declarations made by producers for taxation purposes. Direct control of drug prices is unavoidable in India because the option of indirect control at the time of procurement by public health agencies and insurers is not yet available, as in Europe and the U.S. Citizens in developed countries are insulated from the vagaries of market pricing: they either do not pay at the point of treatment or get a cash reimbursement. But even here, there is the Tamil Nadu model — under which the pharmaceutical industry supplies quality drugs at a fraction of the market price. What this proves is that the price of a drug in the market cannot be several hundred per cent more than what is paid by official agencies. In the sample case of anti-hypertensive drug atenolol, in 2008-09 prices, a strip of tablets was procured officially by Tamil Nadu for Rs.1.20, while consumers bought it for Rs. 26.30 from the market leader. Clearly, the case for reform and cost-based pricing cannot be overstated. The Centre must also plug loopholes that help manufacturers evade price controls by producing combinations of essential and other medications. A panel of professionals to examine all medicines consumed in the country must be constituted, to prepare a more exhaustive and relevant list of essential drugs.